NNPA Newswire–Sigma Gamma Rho Sorority, Inc. has completed a historic pledge made in 2021 to raise $1 million for
The achievement came just ahead of the international collegiate and nonprofit community service organization’s 101st anniversary, marking over a century of commitment to helping those in need.
At the time of the original announcement, Sigma Gamma Rho had already raised nearly $500,000 for St. Jude. As part of the push to reach $1 million, Sigma Gamma Rho pledged a three-year sponsorship for the annual St. Jude Walk/Run, held during Childhood Cancer Awareness Month each September.
Since then, Sigma Gamma Rho has reached its goal in large part through its participation in the St. Jude Walk/Run. In 2023, the organization entered more than 200 Walk/Run teams in cities across the United States, helping it cross the fundraising finish line this year.
Rasheeda S. Liberty, International Grand Basileus of Sigma Gamma Rho, said, “Sigma Gamma Rho Sorority, Incorporated is grateful for the opportunity to support St. Jude Children’s Research Hospital’s work to find cures and help save the lives of children all over the world. I am proud of the mobilization of our global membership to reach this $1,000,000 milestone, and to have done so just prior to our 101st Founders’ Day.
“This accomplishment aligns with our sorority’s motto, ‘Greater Service, Greater Progress.’ We look forward to continuing our partnership with St. Jude in the years to come.”
Support from organizations such as Sigma Gamma Rho helps ensure that families never receive a bill from St. Jude for treatment, travel, housing or food – so they can focus on helping their child live.
“We’re so grateful for and honored by the incredible heart and dedicated service shown by Sigma Gamma Rho,” said Richard C. Shadyac Jr., president and CEO of ALSAC, the fundraising and awareness organization for St. Jude Children’s Research Hospital.
“This is a milestone accomplishment by Sigma Gamma Rho and its members all over the world that will help St. Jude continue making progress in improving survival rates for children with cancer and other life-threatening diseases.”